Hospital Universitario Dr. Jose E. Gonzalez
Hospital Universitario Dr. Jose E. Gonzalez
Explore linked clinical trials.12 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The FILTRATE Trial: High-Rate Ultrafiltration for Intravascular Congestion | Chronic Disease, Disease Attributes, Edema, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic renal failure syndrome, heart disorder, heart failure, kidney disorder, kidney failure, urinary system disorder | Recruiting | Not applicable | 2026-07-15 | NCT07705269 | |
| Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Not applicable | 2026-07-10 | NCT07694791 | |
| Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy | neurotrophic keratopathy | Recruiting | Not applicable | 2026-05-06 | NCT04604834 | |
| Binocular Visual Therapy and Video Games for Amblyopia Treatment. | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorder | Recruiting | Not applicable | 2026-05-06 | NCT03655912 | |
| Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects | Persistent Epithelial Defect | Recruiting | Not applicable | 2026-05-06 | NCT03653650 | |
| Low Dose Epcoritamab Plus GemOx in R/R DLBCL | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-04-01 | NCT07451652 | |
| Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, overnutrition | Recruiting | Not applicable | 2026-03-27 | NCT07497555 | |
| Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, psoriasis, skin disorder, type 2 diabetes mellitus | Recruiting | Phase 4 | 2026-02-11 | NCT07401992 | |
| Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients | Acute Lymphobkastic Leukemia; Acute Lymphoblastic Leukaemia Recurrent; Philadelphia Chromosome Negative ALL | Recruiting | Phase 2 | 2025-10-02 | NCT07039877 | |
| Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment | acute graft versus host disease | Recruiting | Phase 2 | 2025-04-03 | NCT06904599 | |
| Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL | Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2025-03-20 | NCT06886074 | |
| Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2025-03-20 | NCT06758375 |